ATE331515T1 - Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen - Google Patents

Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen

Info

Publication number
ATE331515T1
ATE331515T1 AT99908079T AT99908079T ATE331515T1 AT E331515 T1 ATE331515 T1 AT E331515T1 AT 99908079 T AT99908079 T AT 99908079T AT 99908079 T AT99908079 T AT 99908079T AT E331515 T1 ATE331515 T1 AT E331515T1
Authority
AT
Austria
Prior art keywords
dideoxy
imino
substituted
glucitolen
treatment
Prior art date
Application number
AT99908079T
Other languages
English (en)
Inventor
Richard A Mueller
Martin L Bryant
Richard A Partis
Original Assignee
Searle Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/023,401 external-priority patent/US20030100532A1/en
Application filed by Searle Llc filed Critical Searle Llc
Application granted granted Critical
Publication of ATE331515T1 publication Critical patent/ATE331515T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
AT99908079T 1998-02-12 1999-02-12 Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen ATE331515T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7450898P 1998-02-12 1998-02-12
US09/023,401 US20030100532A1 (en) 1997-02-14 1998-02-12 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections

Publications (1)

Publication Number Publication Date
ATE331515T1 true ATE331515T1 (de) 2006-07-15

Family

ID=26697090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99908079T ATE331515T1 (de) 1998-02-12 1999-02-12 Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen

Country Status (16)

Country Link
US (2) US6809083B1 (de)
EP (1) EP1061922B9 (de)
JP (1) JP2002502875A (de)
KR (1) KR20010040937A (de)
AT (1) ATE331515T1 (de)
AU (2) AU762125B2 (de)
BR (1) BR9907882A (de)
CA (1) CA2319713C (de)
DE (1) DE69932154T2 (de)
EA (1) EA004705B1 (de)
ES (1) ES2272054T3 (de)
ID (1) ID27290A (de)
MY (1) MY122185A (de)
TR (1) TR200002323T2 (de)
TW (1) TWI222867B (de)
WO (1) WO1999040916A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100532A1 (en) * 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
AU762125B2 (en) 1998-02-12 2003-06-19 G.D. Searle & Co. Use of (N)-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
EP1165080A2 (de) * 1999-02-12 2002-01-02 G.D. SEARLE & CO. Verwendung von substituierten 1,5-dideoxy-1,5-imino-d-glucitol-derivaten zur behandlung von hepatitis-virus-infektionen
AU3858600A (en) * 1999-02-12 2001-02-19 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
DE60037664T2 (de) * 1999-08-10 2008-12-24 The Chancellor, Masters And Scholars Of The University Of Oxford Langkettige n-alkyl verbindungen und deren oxa-derivate zur verwendung als anitvirale mittel
AU2001236938A1 (en) * 2000-02-14 2001-08-27 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
AU2013203974B2 (en) * 2000-05-23 2016-06-02 Idenix Pharmaceuticals, Inc. Methods and compositions for treating hepatitis C virus
WO2001092282A2 (en) 2000-05-26 2001-12-06 Idenix (Cayman) Limited Methods and compositions for treating flaviviruses and pestiviruses
WO2003037265A2 (en) * 2001-10-30 2003-05-08 Thomas Jefferson University Method of treating viral infections
WO2006085141A2 (en) * 2004-08-13 2006-08-17 Migenix Inc. Compositions and methods for treating or preventing hepadnaviridae infection
WO2006133447A1 (en) * 2005-06-08 2006-12-14 Amicus Therapeutics, Inc. Crystalline sugar compositions and method of making
WO2006133448A1 (en) * 2005-06-08 2006-12-14 Amicus Therapeutics, Inc. Stabilization of triflated compounds
WO2008045015A1 (en) * 2005-06-08 2008-04-17 Amicus Therapeutics, Inc. Imino and amino sugar purification
US7473683B2 (en) 2005-09-14 2009-01-06 The Board Of Trustees Of The Leland Stanford Junior University Nonpolar thymidine analogs
CN101489554A (zh) * 2006-05-24 2009-07-22 联合治疗公司 脱氧吉瑞霉素和d-阿拉伯胶素醇类似物及使用方法
EP2356990A3 (de) 2006-08-02 2011-10-19 University of Oxford Liposomen-Behandlung von Virusinfektionen
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
CA2753195C (en) 2009-02-23 2015-06-02 United Therapeutics Corporation Iminosugars and methods of treating viral diseases
WO2010109330A2 (en) * 2009-03-27 2010-09-30 University Of Oxford Cholesterol level lowering liposomes
EP2440205B1 (de) 2009-06-12 2014-08-27 United Therapeutics Corporation Iminozucker zur verwendung in der behandlung von bunyaviralen und togaviralen erkrankungen
CN102625801B (zh) * 2009-09-04 2015-09-09 联合治疗公司 治疗痘病毒感染的方法
IN2014MN02539A (de) 2012-06-06 2015-07-24 Unither Virology Llc
SG11201703330YA (en) 2014-11-05 2017-05-30 Emergent Virology Llc Iminosugars useful for the treatment of viral diseases
CA3009996A1 (en) * 2016-01-08 2017-07-13 Arbutus Biopharma Corporation Therapeutic compositions and methods for treating hepatitis b

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1555654A (en) 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4065562A (en) 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
US4012448A (en) 1976-01-15 1977-03-15 Stanford Research Institute Synthesis of adriamycin and 7,9-epiadriamycin
NO154918C (no) 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
GB2020278B (en) 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
JPS5562004A (en) 1978-11-02 1980-05-10 Kureha Chem Ind Co Ltd Control agent against plant viral disease
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
DE3049446A1 (de) 1980-12-30 1982-07-29 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,5-didesoxy-1,5-imino-d-glucitol und dessen n-derivaten
ZA822995B (en) 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
JPS63501925A (ja) 1985-12-23 1988-08-04 フレツド　ハツチンソン　キヤンサ−　リサ−チ　センタ− レトロウイルスの複製、感染及び疾病誘発の制御
GB2186485B (en) 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
DE3611841A1 (de) 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
CA1316459C (en) 1987-12-21 1993-04-20 Raymond Allen Dwek Method of inhibiting virus
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus
FI101344B (fi) 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseut tisesti aktiivista ainetta
US5041441A (en) 1988-04-04 1991-08-20 The Regents Of The University Of Michigan Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol
EP0350012A3 (de) 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antivirale Zusammensetzung
US5144037A (en) * 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US5310745A (en) 1988-11-03 1994-05-10 G. D. Searle & Co. Antiviral compounds
US5003072A (en) * 1988-11-03 1991-03-26 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
US5221746A (en) * 1988-11-03 1993-06-22 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-D-glucitol derivatives
US4957926A (en) 1988-12-22 1990-09-18 Monsanto Company Method of treating herpesviruses
US5011829A (en) 1989-06-02 1991-04-30 G. D. Searle & Co. Pharmaceutical composition and method of inhibiting virus
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement
DE4009561A1 (de) * 1990-03-24 1991-09-26 Bayer Ag Neue desoxynojirimycinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5536732A (en) 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5151519A (en) 1990-05-07 1992-09-29 G. D. Searle & Co. Process for the preparation of 1,5-(alkylimino)-1,5-dideoxy-d-glucitol and derivatives thereof
JP3162123B2 (ja) 1990-09-20 2001-04-25 モンサント カンパニー Ｎ−置換−１−デオキシノジリマイシンの製造方法
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5190765A (en) 1991-06-27 1993-03-02 Alza Corporation Therapy delayed
ZA931934B (en) 1992-03-18 1993-03-18 Us Bioscience Compostitions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals
IL105090A (en) 1992-03-18 1998-08-16 Us Bioscience Acid N) phosphonoacetyl (Aspartic L in a broad spectrum antiviral agent
US5258518A (en) 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5331096A (en) 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
WO1994004546A1 (en) 1992-08-14 1994-03-03 Nippon Shinyaku Co., Ltd. Moranoline derivative
FR2700267B1 (fr) 1993-01-13 1995-03-17 Oreal N-acyl amino déoxy alditols, et leur utilisation dans des compositions cosmétiques ou dermopharmaceutiques.
DE69419601T2 (de) 1993-03-17 1999-12-02 Kao Corp Aminderivate und sie enthaltende dermatologische zubereitungen
US5399567A (en) 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
AU7518694A (en) 1993-08-20 1995-03-21 G.D. Searle & Co. Retroviral protease inhibitors and combinations thereof
US6093702A (en) * 1993-12-20 2000-07-25 The United States Of America As Represented By The Department Of Health And Human Services Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
DE69421828T2 (de) * 1994-01-13 2000-04-20 Searle & Co Verwendung von 1,5-dideoxy-1,5-imino-d-glucitol n-alkylderivaten zur behandlung von hepatitis b infektionen
WO1995022975A1 (en) * 1994-02-25 1995-08-31 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
US5451679A (en) 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
FR2731150B1 (fr) 1995-03-03 1997-04-18 Oreal Utilisation de composes amphiphiles en tant qu'agent epaississant de milieux non aqueux
US5763470A (en) 1995-06-07 1998-06-09 Sugen Inc. Benzopyran compounds and methods for their use
WO1997000881A1 (en) 1995-06-22 1997-01-09 Nippon Shinyaku Co., Ltd. Moranoline derivatives
JP2001512462A (ja) 1997-02-14 2001-08-21 ジー．ディー．サール アンド カンパニー Ｎ−置換−１，５−ジデオキシ−１，５−イミノ−ｄ−グルシトール化合物の、肝炎ウイルス感染の治療のための組み合わせ療法における使用
US6465487B1 (en) 1997-12-11 2002-10-15 Synergy Pharmaceuticals, Inc. Inhibition of membrane-associated viral replication
AU762125B2 (en) 1998-02-12 2003-06-19 G.D. Searle & Co. Use of (N)-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections

Also Published As

Publication number Publication date
CA2319713C (en) 2012-06-26
JP2002502875A (ja) 2002-01-29
CA2319713A1 (en) 1999-08-19
US6809083B1 (en) 2004-10-26
AU2003248024A1 (en) 2003-10-30
ES2272054T3 (es) 2007-04-16
AU762125B2 (en) 2003-06-19
EA004705B1 (ru) 2004-06-24
EP1061922B1 (de) 2006-06-28
TWI222867B (en) 2004-11-01
EP1061922B9 (de) 2007-03-07
AU2759599A (en) 1999-08-30
DE69932154T2 (de) 2007-05-31
US20050267153A1 (en) 2005-12-01
KR20010040937A (ko) 2001-05-15
DE69932154D1 (de) 2006-08-10
EA200000836A1 (ru) 2001-04-23
TR200002323T2 (tr) 2000-12-21
WO1999040916A1 (en) 1999-08-19
MY122185A (en) 2006-03-31
EP1061922A1 (de) 2000-12-27
BR9907882A (pt) 2000-10-17
ID27290A (id) 2001-03-22

Similar Documents

Publication Publication Date Title
ATE331515T1 (de) Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen
DE60039729D1 (de) N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen
CA2119006A1 (en) Composition and method of treating hepatitis c
KR0179637B1 (en) Diaromatic substituted compounds as anti-hiv-1 agents
EP1435974A4 (de) Verfahren und zusamemnsetzungen zur behandlung des hepatitis-c-virus mit 4'-modifizierten nucleosiden
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
DE69925256D1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
EP1128832A4 (de) Verbindungen, zusammenstellungen und methoden zur phophylaxe und behandlung von viralen infektionen und damit verbundenen erkrankungen
DE69830241D1 (de) Verwendung von n-substituierten 1,5-dideoxy-1,5-imino-d-glucitol verbindungen in der kombinationstherapie der vom hepatitisvirus verursachten infektionen
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
IL136690A0 (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
TR200003011T2 (tr) Yeni dihidropirimidinler.
MY141594A (en) 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
DE69811062D1 (de) Polyaromatische antivirale zusammensetzungen
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
ZA943896B (en) Pharmaceutical agents for treatment of emesis
ATE77234T1 (de) Aromatische verbindungen mit amider struktur, derivate von aminobenzoesaeuren, hydroxybenzoesaeuren, zimtsaeuren, urocansaeuren und benzimidazolen, die uvb und/oder uva absorbieren.
ES2036526T3 (es) Composiciones de interferon.
ES2175356T3 (es) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares.
ES2102772T3 (es) Compuesto citotoxico y antiviral.
DE69838980D1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
DK0393530T3 (da) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oner og -thioner og deres anvendelse til forebyggelse eller behandling af AIDS
AR019532A1 (es) COMPOSICIoN FARMACÉUTICA DEL COMPUESTO 1,5-DIDEOXI-1,5-IMIN-D-GLUCITOL N-SUSTITUIDO
ZA871140B (en) Synergistic chemical compositions for treating salmonellosis
TR200100043T2 (tr) Ağrı tedavisinde ilaç hazırlanmasında tetra hidropiridin(veya 4-Hidroksipipeidin)-butilozollerin türevleri

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties